Lab Information
Jesse Papenburg (MD)
ScientistCentre for Outcomes Research and Evaluation
Department of Pediatrics (McGill)
Research Profile
Keywords
Influenza • respiratory syncytial virus (RSV) • children • epidemiology • diagnosis • COVID-19Research Interests
My research focuses on the epidemiology, diagnosis, treatment, and prevention of severe viral lower respiratory tract infections in children. I actively engage in knowledge translation in my field by contributing to national and provincial guidelines on RSV immunoprophylaxis, influenza antiviral treatment, and SARS-CoV-2 diagnostics and treatment. I am also a voting member of Canada's National Advisory Committee on Immunization (NACI) and chair of NACI’s influenza working group.Team Members
| Name | Position |
|---|
Latest Publications
- Prosty, C., Katergi, K., Papenburg, J., Lawandi, A., Lee, T. C., Shi, H., Burnham, P., Swem, L., Routy, B., Yansouni, C. P. & Cheng, M. P. (2024). Causal role of the gut microbiome in certain human diseases: a narrative review. eGastroenterology, vol. 2, p. e100086.
- Farrar, D. S., Bettinger, J. A., Campigotto, A. J., Deeks, S. L., Drouin, O., Embree, J. E., Haddad, E., Halperin, S. A., Jadavji, T., Kazmi, K., King, M., Moore Hepburn, C., Papenburg, J., Purewal, R., Sadarangani, M., Sauvé, L., Yeung, R. S. M., Top, K. A., Kakkar, F., Morris, S. K. & Canadian Immunization Monitoring Program, Active (IMPACT) Investigators (2025). Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT study. Pediatric research.
- Raad, C., Ouldali, N., Lebel, M., Paquette, M., Gilca, R., Papenburg, J., Lewin, A. & Renaud, C. (2024). Use of the moving epidemic method to guide the launch of palivizumab immunization campaigns for respiratory syncytial virus in Québec, Canada. Canadian journal of public health = Revue canadienne de sante publique.
- Marom, A., Papenburg, J. & Burstein, B. (2024). The Critical Lens: It is time to start using the right test for febrile young infants. Paediatrics & child health, vol. 29, p. 419-421.
- Gil, A., Siu, W., Papenburg, J., Gil, A., Siu, W. & Papenburg, J. (2024). Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2024-2025. Canada communicable disease report = Releve des maladies transmissibles au Canada, vol. 50, p. 381-386.
- Doyon-Plourde, P., Sinilaite, A. & Papenburg, J. (2024). Summary of the National Advisory Committee on Immunization (NACI) Supplemental Guidance on Influenza Vaccination in Adults 65 Years of Age and Older. Canada communicable disease report = Releve des maladies transmissibles au Canada, vol. 50, p. 387-392.
- Reszetnik, G., Hammond, K., Mahshid, S., AbdElFatah, T., Nguyen, D., Corsini, R., Caya, C., Papenburg, J., Cheng, M. P. & Yansouni, C. P. (2024). Next-generation rapid phenotypic antimicrobial susceptibility testing. Nature communications, vol. 15, p. 9719.
- Charland, K., Quach, C., Papenburg, J., Pierce, L., Tuong Nguyen, C., Saucier, A., Barbosa Da Torre, M., Hamelin, M.-È., Carbonneau, J., Boivin, G. & Zinszer, K. (2024). Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada. Vaccine, vol. 43, p. 126489.
- Charland, K., Pierce, L., Saucier, A., Hamelin, M.-È., Barbosa Da Torre, M., Carbonneau, J., Nguyen, C. T., De Serres, G., Papenburg, J., Boivin, G., Quach, C. & Zinszer, K. (2024). Omicron incidence and seroprevalence among children in Montreal, Canada, in early 2023: final results from the longitudinal EnCORE serology study. Epidemiology and infection, vol. 152, p. e103.
- Assad, Z., Papenburg, J. & Ouldali, N. (2024). Nirsevimab-a breakthrough in respiratory syncytial virus bronchiolitis. The Lancet. Child & adolescent health, vol. 8, p. 708-709.
See also
